CONCLUSIONS: Evidence around KDT shows it can be implemented safely as an adjunctive treatment for adults with drug-resistant epilepsy and is reasonable to consider following the failure of two adequate antiseizure medications. Structured implementation may reduce seizure frequency, improve quality of life, and reduce the pharmacological burden. Multicenter prospective studies are needed to further assess efficacy, safety, and resource utilization. These recommendations contribute to closing the...
Source: PubMed - functional seizures
ยทPublished 27 Oct 2026 ยทImported 27 Oct 2026
Relevancy: Not reviewed
Read the article